Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CTSS | P25774 | 1/20 | 0.34 |
| ▸ | CTSK | P43235 | 1/20 | 0.34 |
| ▸ | PDE2A | O00408 | 1/20 | 0.33 |
| ▸ | IDO1 | P14902 | 2/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.30 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.30 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.30 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.30 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.30 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6288802 | 0.93 | CYP3A4 (0.34) | CYP3A4MAPK1TSHRTDP1CTSS | |
| SCHEMBL134606 | 0.89 | CYP3A4 (0.35) | CYP3A4MAPK1TSHRTDP1CTSS | |
| SCHEMBL215394 | 0.85 | PDE2A (0.35) | CYP3A4MAPK1TSHRTDP1CTSS | |
| SCHEMBL23175324 | 0.81 | KIF11 (0.36) | CYP3A4MAPK1TSHRPDE2AIDO1 | |
| Trimethylammonium SCHEMBL219375 | 0.80 | CES2 (0.38) | PDE2AIDO1CES2MAPT | |
| SCHEMBL41567 | 0.79 | CES2 (0.44) | CYP3A4MAPK1TSHRTDP1PDE2A | |
| SCHEMBL29853969 | 0.79 | PDE2A (0.36) | CYP3A4MAPK1TSHRTDP1CTSS | |
| SCHEMBL628169 | 0.78 | GABRA2 (0.36) | CYP3A4MAPK1TSHRTDP1CTSS | |
| SCHEMBL30509222 | 0.78 | CES2 (0.39) | TSHRPDE2AIDO1CES2MAPT | |
| SCHEMBL226082 | 0.77 | CES2 (0.42) | CYP3A4MAPK1TSHRTDP1PDE2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 818 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114867758-B | Metallocene and method thereof | 埃克森美孚化学专利公司 | 2025-04-08 | — | — | CN | claimed |
| CN-113614123-B | Transition metal bis (phenoxide) complexes and their use as olefin polymerization catalysts | 埃克森美孚化学专利公司 | 2024-01-23 | — | — | CN | claimed |
| US-11760814-B2 | 1,5 diazabicyclooctane ligand systems and methods therewith | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-09-19 | — | — | US | claimed |
| CN-116490528-A | Polymer compositions containing cyclics obtained using transition metal bis (phenoxide) catalyst complexes and process for their preparation | 埃克森美孚化学专利公司 | 2023-07-25 | — | — | CN | claimed |
| CN-116323694-A | Bis (heterocyclic-alkoxide) lewis base catalysts and methods thereof | 埃克森美孚化学专利公司 | 2023-06-23 | — | — | CN | claimed |
| EP-4196507-A1 | CYCLIC CONTAINING POLYMER COMPOSITIONS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND PROCESS FOR PRODUCTION THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2023-06-21 | — | — | EP | claimed |
| CN-113423742-B | Bis (arylphenoxide) lewis base catalysts and methods thereof | 埃克森美孚化学专利公司 | 2023-05-05 | — | — | CN | claimed |
| CN-113423744-B | Lewis base catalyst and method thereof | 埃克森美孚化学专利公司 | 2023-05-05 | — | — | CN | claimed |
| EP-4103628-A1 | PROPYLENE POLYMERS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND HOMOGENEOUS PROCESS FOR PRODUCTION THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2022-12-21 | — | — | EP | claimed |
| EP-4103629-A1 | POLYETHYLENE COMPOSITIONS OBTAINED USING TRANSITION METAL BIS(PHENOLATE) CATALYST COMPLEXES AND HOMOGENEOUS PROCESS FOR PRODUCTION THEREOF | ExxonMobil Chemical Patents Inc. (US) | 2022-12-21 | — | — | EP | claimed |
| US-20050239981-A1 | Phosphorus bridged metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-10-27 | — | — | US | claimed |
| US-20050239980-A1 | Phosphorus substituted metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2005-10-27 | — | — | US | claimed |
| EP-1546223-A2 | SUPERCRITICAL POLYMERIZATION PROCESS AND POLYMERS PRODUCED THEREFROM | ExxonMobil Chemical Patents Inc. (US) | 2005-06-29 | — | — | EP | claimed |
| EP-1521758-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | Exxonmobil Chemical Patents Inc. (US) | 2005-04-13 | — | — | EP | claimed |
| US-20040266961-A1 | Catalyst composition II | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-12-30 | — | — | US | claimed |
| WO-2004106390-A2 | POLYMERIZATION AND OLIGOMERIZATION CATALYST WITH TRIDENTATE OR TETRADENTATE LIGAND | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-12-09 | — | — | WO | claimed |
| WO-2004026923-A9 | SUPERCRITICAL POLYMERIZATION PROCESS AND POLYMERS PRODUCED THEREFROM | EXXONMOBIL CHEM PATENTS INC (US) | 2004-09-10 | — | — | WO | claimed |
| US-20040122191-A1 | Supercritical polymerization process and polymers produced therefrom | EXXONMOBIL CHEMICAL PATENTS INC | 2004-06-24 | — | — | US | claimed |
| WO-2004026923-A2 | SUPERCRITICAL POLYMERIZATION PROCESS AND POLYMERS PRODUCED THEREFROM | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-04-01 | — | — | WO | claimed |
| WO-2004007509-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-01-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11760814-B2 | 1,5 diazabicyclooctane ligand systems and methods therewith | ODC1, DDT, OXGR1 | CYP3A4 803/4885MAPK1 2002/4885TSHR 4711/4885 |
| US-20050239981-A1 | Phosphorus bridged metallocene compounds for olefin polymerization | PYM1, ZNF207, POLL | CYP3A4 3759/4885MAPK1 2369/4885TSHR 3182/4885 |
| US-20040266961-A1 | Catalyst composition II | MLX, CBX2, BMX | CYP3A4 2959/4885MAPK1 4372/4885TSHR 4496/4885 |
| US-20050239980-A1 | Phosphorus substituted metallocene compounds for olefin polymerization | CCRL2, ARL1, OSBP2 | CYP3A4 2753/4885MAPK1 3022/4885TSHR 2600/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.